Lipella Pharmaceuticals Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 53630L100 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Sabby Management, LLC 13G/A	4.9%	60,325	13G/A	1/3/2025 Event 12/31/2024
Sabby Management, LLC	4.9%	60,325
Sabby Volatility Warrant Master Fund Ltd	4.9%	60,325
Hal Mintz	4.9%	60,325

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2024 Q3	6	84.8 k	$39.7 k	$0
2024 Q2	8	630 k	$284 k	$0
2024 Q1	10	380 k	$260 k	$0
2023 Q4	8	370 k	$377 k	$0
2023 Q3	5	39.6 k	$59.5 k	$0
2023 Q2	5	38.6 k	$82.5 k	$0
2023 Q1	7	53.3 k	$104 k	$0
2022 Q4	3	14.1 k	$44.7 k	$0